EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy

Hye In Lee, Jaeman Son, Byungchul Cho, Youngmoon Goh, Jinhong Jung, Jin-Hong Park, Eui Kyu Chie, Kyung Su Kim, Young-Hak Kim, Hyun-Cheol Kang, Sang Min Yoon

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.02.013 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Hye In Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Radiosurgery, Liver Neoplasms, Heart Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop and validate a prediction model for major adverse cardiac events (MACEs) in hepatocellular carcinoma patients treated with stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: We retrospectively identified 1893 hepatocellular carcinoma patients who received SBRT at 2 institutions, with one serving as the development cohort (n = 1473) and the other as the validation cohort (n = 420). A MACE was defined as any cardiac event classified as grade 3 or higher according to the Common Terminology Criteria for Adverse Events, version 5.0. We evaluated 15 clinical and 88 dosimetric parameters using bootstrapped forward selection and area under the curve (AUC) to identify significant predictors for MACEs. Based on these factors, we constructed the Cardiac Event Index (CEI) model, categorizing patients into distinct risk groups. Model performance was assessed for discrimination, efficiency, and calibration. RESULTS: The MACE occurrence rate was 5.8% in the development cohort and 6.7% in the validation cohort. Five parameters were selected for predicting MACEs and were incorporated into the CEI model using the following equation: CEI = age score + hypertension + current smoking + (2 × history of cardiac disease) + (0.05 × heart-V5 [%]), which yielded an AUC of 0.770 for MACEs and 0.750 for coronary artery disease. The CEI model stratified patients into low-, intermediate-, and high-risk groups that had MACE incidence rates of 0.4%, 4.9%, and 22.8%, respectively. The impact of heart-V5 on MACEs was minimal in low- and intermediate-risk groups but pronounced in the high-risk group. In the validation cohort, the CEI model yielded an AUC of 0.809 for MACEs and 0.793 for coronary artery disease. CONCLUSIONS: The CEI model demonstrated robust performance in predicting MACEs, revealing the significant influence of clinical factors and the minimal impact of SBRT. This model can inform evidence-based decisions regarding cardiac dose optimization in SBRT planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularRadiosurgeryLiver NeoplasmsHeart DiseasesHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAged, 80 and overAge FactorsAdultSmokingArea Under Curve

Autor:innen und Institutionen

  • Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic addre…
  • Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: drsmyoon@amc.seoul.kr.

Zitieren

APA

Lee, H. I., Son, J., Cho, B., Goh, Y., Jung, J., Park, J. H., Chie, E. K., Kim, K. S., Kim, Y. H., Kang, H. C., & Yoon, S. M. (2025). Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.02.013

Vancouver

Lee HI, Son J, Cho B, Goh Y, Jung J, Park JH, et al. Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.02.013

BibTeX
@article{Lee2025,
  author = {Lee, Hye In and Son, Jaeman and Cho, Byungchul and Goh, Youngmoon and Jung, Jinhong and Park, Jin-Hong and Chie, Eui Kyu and Kim, Kyung Su and Kim, Young-Hak and Kang, Hyun-Cheol and Yoon, Sang Min},
  title = {Development and Validation of a Prediction Model for Cardiac Events in Patients With Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.02.013}
}
Kostenlos starten →